Role of SIRT6 in the pancreatic beta cell aging
Role of SIRT6 in the pancreatic beta cell aging
批准号:
10641670
负责人:
X Charlie Dong
金额:
$19.81万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-15 至 2025-02-28
关键词:
AccelerationAgeAge YearsAgingBeta CellBiological ProcessCalcium SignalingCell AgingCell DeathCell ProliferationCell membraneCell physiologyDNA DamageDataDeacetylaseDefectDevelopmentDiabetes MellitusDietDiseaseEpigenetic ProcessFemaleGene ExpressionGene Expression RegulationGeneral PopulationGenesGlucoseGlucose IntoleranceGuanosine Triphosphate PhosphohydrolasesHDAC4 geneHistologicHomeostasisHumanImpairmentInsulinInterventionIslets of LangerhansKnock-outKnockout MiceKnowledgeLifeLiteratureLongevityMetabolicMetabolismMissionMitochondriaModelingMolecular and Cellular BiologyMonitorMonomeric GTP-Binding ProteinsMusNon-Insulin-Dependent Diabetes MellitusOxidative StressPersonsPhenotypePhysiologicalPhysiologyPlayPopulationPremature MortalityPrevalencePreventionProcessProteinsPublic HealthRegulationResearchRisk FactorsRoleSirtuinsStructure of beta Cell of isletTestingTransgenesTransgenic MiceUnited States National Institutes of Healthage relatedanti agingblood glucose regulationburden of illnesscell agecell injurydiabetes pathogenesisendocrine pancreas developmentepigenetic regulationexpectationgene functionglucose metabolismhigh riskhuman old age (65+)improvedinnovationinsightinsulin secretionmalemiddle agemolecular phenotypemouse modelnew therapeutic targetnoveloverexpressiontherapeutic developmenttransgene expressionvoltage
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
During aging, pancreatic beta cells undergo a decline in insulin secretion capacity, and this
contributes to nearly 3-fold high diabetes prevalence in people aged over 65 years compared to the
general population. Sirtuin 6 (SIRT6), a histone deacetylase, has been suggested to be a longevity factor.
In the preliminary study, we have demonstrated that SIRT6 is required to maintain normal beta cell
function and SIRT6 is downregulated in the beta cells during aging. Therefore, we hypothesize that SIRT6
plays an important role in the protection of pancreatic beta cells against aging-associated cellular
damage. In this application, we will investigate the SIRT6 function and mechanism in the regulation of
pancreatic beta cell aging. It is our expectation that the findings from this project will advance our
understanding of the fundamental process of the aging of pancreatic beta cells and provide potential
novel targets for the development of prevention and treatment of the age-related diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The pathophysiological function of PNPLA3-148M variant in alcohol-induced liver injury
-
批准号:10366395
-
项目类别:
-
资助金额:$46.02万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
Role of SIRT6 in the pancreatic beta cell aging
-
批准号:10371337
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
The pathophysiological function of PNPLA3-148M variant in alcohol-induced liver injury
-
批准号:10613405
-
项目类别:
-
资助金额:$44.59万
-
财政年份:2022
-
负责人:X Charlie Dong
-
依托单位:
Role of ATG14 in the regulation of hepatic function
-
批准号:10596539
-
项目类别:
-
资助金额:$43.36万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Role of ATG14 in the regulation of hepatic function
-
批准号:10371047
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Epigenetic regulation in liver fibrosis
-
批准号:10640141
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Epigenetic regulation in liver fibrosis
-
批准号:10172893
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Epigenetic regulation in liver fibrosis
-
批准号:10428589
-
项目类别:
-
资助金额:$45.71万
-
财政年份:2020
-
负责人:X Charlie Dong
-
依托单位:
Role of sirtuin 6 in the protection of liver from the alcohol-induced injury
-
批准号:9244917
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2017
-
负责人:X Charlie Dong
-
依托单位:
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease
-
批准号:9303199
-
项目类别:
-
资助金额:$34.91万
-
财政年份:2016
-
负责人:X Charlie Dong
-
依托单位:
Sestrin3 in the pathogenesis of alcoholic and non-alcoholic fatty liver disease
-
批准号:9188590
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2016
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:8234620
-
项目类别:
-
资助金额:$33.86万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:8617269
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:8448636
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Regulation of hepatic lipid metabolism by a novel Foxo pathway
-
批准号:9018006
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2012
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:7685845
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:7769879
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:8001274
-
项目类别:
-
资助金额:$7.1万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:8019582
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:X Charlie Dong
-
依托单位:
Role of Pyruvate Dehydrogenase Kinases in Glucose Homeostasis
-
批准号:7320914
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2007
-
负责人:X Charlie Dong
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: